Wilson Sonsini Goodrich & Rosati represented PvP Biologics in the acquisition. Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) announced that it has acquired PvP Biologics, Inc. following the…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now